Viewing Study NCT03946358


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-01-06 @ 12:37 AM
Study NCT ID: NCT03946358
Status: COMPLETED
Last Update Posted: 2024-12-20
First Post: 2019-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)
Sponsor: Centre Hospitalier Universitaire de Besancon
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-02-18
Start Date Type: ACTUAL
Primary Completion Date: 2024-03-01
Primary Completion Date Type: ACTUAL
Completion Date: 2024-11-01
Completion Date Type: ACTUAL
First Submit Date: 2019-05-07
First Submit QC Date: None
Study First Post Date: 2019-05-10
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-12-19
Last Update Post Date: 2024-12-20
Last Update Post Date Type: ACTUAL